Tags: Loeb | Third | Point | Sothebys

Loeb's Third Point Sues Sotheby's Over Poison Pill Trigger

Tuesday, 25 Mar 2014 05:34 PM

Dan Loeb’s Third Point LLC took its fight to add directors to the Sotheby’s board to court, seeking to overturn a poison pill that would be triggered when an activist investor obtains 10 percent of the auction house’s stock.

Third Point filed a lawsuit Tuesday in Delaware Chancery Court against Sotheby’s and its board. The hedge fund said the poison pill, normally used as a takeover defense, is being employed to impede a proxy contest and maintain the status quo.

“The terms of the poison pill demonstrate that the board has no genuine concern with a takeover attempt, but are instead intended to thwart Third Point, Sotheby’s largest shareholder, from effectively running a slate of director candidates,” according the complaint provided by Third Point.

Sotheby’s, under pressure by Loeb to increase shareholder value, this month rejected a proposal by the hedge-fund manager to add three directors to its board, saying the nominees don’t add relevant skills.

The case is Third Point LLC v. Ruprecht, CA9469. Delaware Chancery Court (Wilmington).

© Copyright 2017 Bloomberg News. All rights reserved.

 
1Like our page
2Share
InvestingAnalysis
Dan Loeb's Third Point LLC took its fight to add directors to the Sotheby's board to court, seeking to overturn a poison pill that would be triggered when an activist investor obtains 10 percent of the auction house's stock.
Loeb,Third,Point,Sothebys
169
2014-34-25
Tuesday, 25 Mar 2014 05:34 PM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved